Advances in Diagnosis and Treatment of Neurofibromatosis 1

Explore advances in the diagnosis and treatment of Neurofibromatosis 1 through this keynote presentation from the 2022 Cancer Genomics Consortium Annual Meeting. Delve into the mutation spectrum, pathogenesis, and the role of volumetric MRI in managing this condition. Gain insights into ongoing clinical trials, inhibition strategies, and mutations associated with Neurofibromatosis 1. Discover future opportunities in the field and engage with the speaker's concluding remarks and audience questions. Learn from expert Bruce Korf as he shares cutting-edge research and developments in this hour-long presentation, aimed at improving patient care and outcomes for those affected by Neurofibromatosis 1.

Introduction
Bruce Korff
Mutation Spectrum
Pathogenesis
Volumetric MRI
Clinical Trials
Inhibition
Mutations
Future Opportunities
Conclusion
Questions